| |
Greece
|
Cyprus
|
Difference
|
p-value
|
|
Absolutely
|
2.90%
|
4.15%
|
-1.25%
|
0.395
|
|
Enough
|
14.99%
|
32.64%
|
-17.65%
|
0.000
|
|
Not really
|
49.23%
|
55.96%
|
-6.73%
|
0.079
|
|
Almost not
|
10.48%
|
4.66%
|
5.82%
|
0.001
|
|
Not at all
|
22.40%
|
2.59%
|
19.81%
|
0.000
|
| |
Generally, what do you think about the effectiveness of new drug products in comparison to the older ones already on the market?
|
| |
Greece
|
Cyprus
|
Difference
|
p-value
|
|
Clearly more effective
|
18.73%
|
24.35%
|
-5.62%
|
0.084
|
|
Rather more effective
|
43.62%
|
61.14%
|
-17.52%
|
0.000
|
|
Do not differ significantlly
|
30.15%
|
14.51%
|
15.64%
|
0.000
|
|
Do not differ at all
|
7.49%
|
0.00%
|
7.49%
|
0.000
|
| |
Which sources do you consult in order to get information for the launch of new drugs?
|
| |
Greece
|
Cyprus
|
Difference
|
p-value
|
|
Scientific journals
|
78.99%
|
76.68%
|
2.31%
|
0.477
|
|
Medical congresses
|
75.10%
|
7.25%
|
63.85%
|
0.000
|
|
Pharmaceutical representatives
|
77.33%
|
88.08%
|
-10.75%
|
0.000
|
|
Scientific medical societies
|
38.87%
|
51.30%
|
-12.43%
|
0.001
|
|
Internet
|
30.32%
|
41.45%
|
-11.13%
|
0.003
|
